1. Home
  2. ONCO vs STKH Comparison

ONCO vs STKH Comparison

Compare ONCO & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCO
  • STKH
  • Stock Information
  • Founded
  • ONCO 2018
  • STKH 2018
  • Country
  • ONCO United States
  • STKH Israel
  • Employees
  • ONCO N/A
  • STKH N/A
  • Industry
  • ONCO Biotechnology: Pharmaceutical Preparations
  • STKH Packaged Foods
  • Sector
  • ONCO Health Care
  • STKH Consumer Staples
  • Exchange
  • ONCO Nasdaq
  • STKH Nasdaq
  • Market Cap
  • ONCO 1.8M
  • STKH 1.9M
  • IPO Year
  • ONCO 2022
  • STKH 2021
  • Fundamental
  • Price
  • ONCO $2.84
  • STKH $0.89
  • Analyst Decision
  • ONCO
  • STKH
  • Analyst Count
  • ONCO 0
  • STKH 0
  • Target Price
  • ONCO N/A
  • STKH N/A
  • AVG Volume (30 Days)
  • ONCO 1.8M
  • STKH 851.8K
  • Earning Date
  • ONCO 08-28-2025
  • STKH 08-29-2025
  • Dividend Yield
  • ONCO N/A
  • STKH N/A
  • EPS Growth
  • ONCO N/A
  • STKH N/A
  • EPS
  • ONCO N/A
  • STKH N/A
  • Revenue
  • ONCO $1,925,313.00
  • STKH $10,000.00
  • Revenue This Year
  • ONCO N/A
  • STKH N/A
  • Revenue Next Year
  • ONCO N/A
  • STKH N/A
  • P/E Ratio
  • ONCO N/A
  • STKH N/A
  • Revenue Growth
  • ONCO 153.70
  • STKH N/A
  • 52 Week Low
  • ONCO $2.61
  • STKH $0.80
  • 52 Week High
  • ONCO $656.88
  • STKH $17.20
  • Technical
  • Relative Strength Index (RSI)
  • ONCO 36.48
  • STKH 36.31
  • Support Level
  • ONCO $2.61
  • STKH $0.80
  • Resistance Level
  • ONCO $4.59
  • STKH $0.92
  • Average True Range (ATR)
  • ONCO 0.36
  • STKH 0.12
  • MACD
  • ONCO -0.04
  • STKH 0.01
  • Stochastic Oscillator
  • ONCO 11.62
  • STKH 20.00

About ONCO Onconetix Inc.

Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: